The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

In the rapidly evolving field of genetic engineering, few names resonate as profoundly as George Church, a geneticist at Harvard University. Known for his groundbreaking work in genomics, Church has ...

PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

NHS officials estimate around 50 people a year will receive treatment now it has been approved for use for certain patients with severe sickle cell disease. | ITV National News ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

In 2011, a woolly mammoth was dug out in near pristine condition after it spent the last 28,000 years frozen solid in the ...

Exchange Traded Concepts LLC trimmed its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form ...

AEye, Inc. , a global leader in adaptive, high-performance lidar solutions, today announced that CFO Conor Tierney will participate in the following conference: Alliance Global Partners (A.G.P.) ...

Questions continue to grow about air safety in the US capital. We hear from Graham Braithwaite, professor of safety and ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.